Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2012
12/19/2012CN101068794B Quinazolines useful as modulators of ion channels
12/18/2012US8334382 Substituted biaryl piperazinyl-pyridine analogues
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334109 Reagent for blood analysis and method of using the same
12/18/2012US8334061 Heterocyclic compound, and light-emitting element, light-emitting device, lighting device, and electronic appliance using heterocyclic compound
12/18/2012US8333988 Targeted delivery using tissue-specific peptidomimetic ligands
12/18/2012CA2702933C Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/18/2012CA2517517C P38 inhibitors and methods of use thereof
12/13/2012WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012WO2012170561A1 N-benzylindole modulators of pparg
12/13/2012WO2012170554A1 N-biphenylmethylindole modulators of pparg
12/13/2012WO2012170035A1 Surfactants with a terminal dialkyl- or cycloalkyl-substituted tertiary amine and inks including the same
12/13/2012WO2012169785A2 Symmetrically structured quinazoline derivatives
12/13/2012WO2012168710A1 Hydantoin derivates as kv3 inhibitors
12/13/2012WO2012103678A9 Pentamethine cyanine fluorescent dyes, preparation methods and uses thereof
12/13/2012WO2011156554A8 Cyclohexyl-azetidinyl antagonists of ccr2
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316178 Piperazines as antimalarial agents
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316170 Imidazole Derivative
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316162 Piperidine and piperazine derivatives
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316153 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
12/13/2012US20120316151 Triazolones as fatty acid synthase inhibitors
12/13/2012US20120316150 Amide compounds useful in therapy
12/13/2012US20120316091 Thickener, grease, method for producing the same,and grease-packed bearing
12/13/2012US20120313506 Quinoxaline Derivative, and Light-Emitting Device, Electronic Device Using the Quinoxaline Derivative
12/13/2012CA2833771A1 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/12/2012EP2532659A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
12/12/2012EP2532658A1 Therapeutic agent for cerebral infarction
12/12/2012EP2532653A1 Benzo[1,2,4]triazines as protein kinase modulators
12/12/2012EP2531499A2 Process for preparing voriconazole by using new intermediates
12/12/2012EP2531492A1 1,2,4-triazine-4-amine derivatives
12/12/2012EP2531488A2 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors
12/12/2012CN102822169A Substituted naphthalenyl-pyrimidine compounds
12/12/2012CN102822166A Processes for the preparation of 5 - lipooxygenase activating protein inhibitors and their intermediates
12/12/2012CN102822163A Crth2 modulators
12/12/2012CN102822150A 1,2,4-triazine-4-amine derivatives
12/12/2012CN102822147A Process for the preparation of alpha-acyloxy beta-formamido amides
12/12/2012CN102816151A Levorotatory meptazinol derivative, preparation method and pharmaceutical application thereof
12/12/2012CN102816150A Indole with bacteriostatic activity and derivatives thereof-triazole compounds, and preparation method thereof
12/12/2012CN101973946B Phenazine-1-carboxylic acids derivative and preparation method thereof
12/12/2012CN101809001B 咪唑衍生物 Imidazole derivatives
12/12/2012CN101500994B 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/12/2012CN101486677B 5HT2C receptor modulators
12/12/2012CN101228152B N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
12/12/2012CN101115803B Dye, ink, ink for inkjet, inkjet recording method, ink sheet, color toner, and color filter
12/11/2012US8329953 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same
12/11/2012US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
12/11/2012US8329899 Pyrazole compounds that modulate HSP90 activity
12/11/2012US8329872 Drug monitoring assay
12/11/2012US8329737 Benzimidazoles as selective kinase inhibitors
12/11/2012US8329712 Heterocyclic antiviral compounds
12/11/2012US8329692 Pyrimidinyl pyridazinone derivatives
12/11/2012US8329688 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
12/11/2012US8329686 Isatin analogues and uses therefor
12/11/2012US8329390 Detection of transmembrane potentials using N,N,N′-trialkyl thiobarbituric acid-derived polymethine oxonols
12/11/2012US8329159 Hepatitis C virus inhibitors
12/11/2012CA2576144C Sigma receptor inhibitors
12/11/2012CA2565237C Quinoxaline inhibitors of hedgehog signalling
12/11/2012CA2557789C Pyrazolyl indolyl derivatives as ppar activators
12/11/2012CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
12/06/2012WO2012166415A1 Heterocyclic autotaxin inhibitors and uses thereof
12/06/2012WO2012166387A1 Neprilysin inhibitors
12/06/2012WO2012165844A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
12/06/2012US20120309984 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
12/06/2012US20120309979 Phosphorescent material, their preparations and applications
12/06/2012US20120309974 Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials
12/06/2012US20120309801 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
12/06/2012US20120309794 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds
12/06/2012US20120309777 Substituted 2-imidazolidones and analogs
12/06/2012US20120309769 N-benzylindole modulators of pparg
12/06/2012US20120309757 N-biphenylmethylindole modulators of pparg
12/06/2012US20120309741 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
12/06/2012US20120309738 Novel compounds
12/06/2012US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012US20120305900 Compound for organic photoelectric device and organic photoelectric device including the same
12/06/2012US20120305851 Materials for Organic Electroluminescent Devices
12/06/2012US20120305074 Photoelectric conversion element and dye for photoelectric conversion element
12/06/2012CA2835216A1 Neprilysin inhibitors
12/05/2012EP2530082A1 Process for preparing 2, 3-disubstituted indoles
12/05/2012EP2529740A1 Methods of preparing 4-Phenyl-6(2,2,2-Trifluoro-1-Phenylethoxy) Pyrimidine-based compounds.
12/05/2012EP2528913A1 Crystalline forms of l-malic acid salt of sunitinib
12/05/2012EP2528911A2 Compositions and methods for enhancing proteasome activity
12/05/2012EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/05/2012EP2528893A2 Small molecules for the modulation of mcl-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders
12/05/2012EP2528606A1 Quinazoline-based t cell proliferation inhibitors
12/05/2012EP2528441A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
12/05/2012CN1894261B Heterocyclic boronic acid compounds
12/05/2012CN102812020A Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
12/05/2012CN102812018A Pyridazine compounds for controlling invertebrate pests
12/05/2012CN102812011A [1,5]-diazocin Derivatives
12/05/2012CN102812003A Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Disordersas As Agonists Of G- Protein Coupled Receptor 43 (GPR43)
12/05/2012CN102807564A Preparation method of irbesartan
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 626